Shares of Moderna slid 9.25% to $125.51 at 13:24 EST on Tuesday, after two sequential sessions in a row of losses. The Nasdaq Stock Market is jumping 0.16% to $12,762.70, after two consecutive sessions in a row of losses. This seems, as yet, a somewhat positive trend exchanging session today.

Moderna’s last close was $138.30, 42.22% below its 52-week high of $178.50.

Moderna’s Sales

Moderna’s sales growth is 1841.7% for the current quarter and 19117.5% for the next. The company’s growth estimates for the ongoing quarter is a negative 2.7% and positive 660% for the next.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $125.51 at 13:24 EST, way under its 52-week high of $178.50 and way above its 52-week low of $17.68.

Moderna’s Moving Average

Moderna’s value is above its 50-day moving average of $116.47 and way above its 200-day moving average of $80.87.

Previous days news about Moderna

Moderna shot cleared in U.S., boosting immunization effort. According to Bloomberg Quint on Sat Dec 19, “Moderna Inc.’s Covid-19 vaccine was cleared by U.S. regulators, the second vaccine to gain emergency authorization this month as a historic mass immunization effort ramps up across the country.”, “Health and Human Services Secretary Alex Azar said on Wednesday that 5.9 million does of Moderna’s vaccine would be sent out nationwide rapidly after the authorization. ”

Moderna, Exxon, Alphabet, Amazon: stocks that defined the week. According to The Wall Street Journal on Sat Dec 19, “Moderna, a ten-year-old biotech that has never had a product cleared by the FDA, expects to deliver a total of 20 million doses by the end of December. “, “U.S. health regulators late Friday permitted use of Moderna’s Covid-19 vaccine, the second shot to get the green light to help end the pandemic. ”

Statement on the U.S. authorization of the Moderna Covid-19 vaccine. According to Business Insider on Sat Dec 19, “Health Canada has been reviewing Moderna’s vaccine since it was submitted on October 12, 2020, and is expediting the review of COVID-19 vaccines. “, “There is still information and data to be provided by Moderna for review. ”

Moderna to begin delivery; London lockdown ordered: virus update. According to Bloomberg Quint on Sat Dec 19, “The boxes containing the Moderna vaccine are lighter than Pfizer’s because they don’t contain the dry ice that’s needed to keep the Pfizer vaccine at ultra-cold temperatures, Wheeler from UPS said.”, “The advisers cast the vote in an emergency meeting Saturday after the Food and Drug Administration authorized use of Moderna’s shot Friday.”

Philippines to start vaccine talks with Moderna by year-end: CNN. According to Bloomberg Quint on Mon Dec 21, “The Philippines will start talks with Moderna Inc. on or before Dec. 30 to secure supply of the company’s coronavirus vaccine, Foreign Affairs Secretary Teodoro Locsin said Monday.”, “”Moderna is interested in giving an allocation,” he said in a live-streamed interview with CNN Philippines, citing Philippine ambassador to the U.S. Jose Manuel Romualdez.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here